Aurionpro announces the successful implementation of Murex Version Upgrade for the Leading Malaysian Bank
Aurionpro announces the successful implementation of the version upgrade of Murex application at for one of the leading banks in Malaysia. Aurionpro, having a team of experienced resources with the requisite skills & experience, successfully completed implementation with smooth transition to the higher version of system post go-live.
Commenting on to this Murex implementation Ms. Soni Hemnani - Managing Director of the division, said that “We are pleased to announce this successful implementation. In the wake of disruptions caused due to pandemic, it was our first 100% remote implementation. This will strengthen our position as a trusted partner with abilities to execute complex upgrade programmes. With the robust team, led by experience leaders & subject matter expertise, we are best placed to grab similar opportunities in this space
Ms. Abhiruchi Khare - Senior Director said “The big day has finally arrived!! We are delighted with the success of one of the key projects. Aurionpro team pioneered in delivery excellence and quality assurance always ensures its clients’ expectations and is committed to deliver at our best
Airtel institutes ESG Committee of Board of Directors
Committee to provide strategic focus towards Airtel’s ESG agenda
Bharti Airtel Limited (“Airtel”), India’s premier communications solutions provider, today announced that it has formed a Committee of Board of Directors (“ESG Committee”) to sharpen its focus towards its Environmental, Sustainability and Governance (ESG) agenda.
Manish Kejriwal, Lead Independent Director on the Board will be the Chairman of the ESG Committee. Other Board members on the Committee are D.K. Mittal, Independent Director; Nisaba Godrej, Independent Director; Rakesh Bharti Mittal, Non-Executive Director and Gopal Vittal, Managing Director & CEO (India and South Asia).
The ESG Committee will provide strategic guidance and oversight to the company’s progress on ESG targets, initiatives and best practices. This will also include initiatives to respond to challenges posed by climate change through sustainable business practices.
Sunil Bharti Mittal, Chairman, Bharti Airtel said: “Businesses have the responsibility to sharpen their ESG agendas to contribute to the global efforts to combat climate change and ensure inclusive growth. Airtel has always set high standards of corporate governance, transparency and has proactively laid out a comprehensive ESG roadmap. This empowered committee ensures that ESG is a priority for the Board in order to create long-term value for all stakeholders through sustainable business practices
Biocon Biologics Collaborates with RSSDI to Expand Access to its Insulins for Children with Type 1 Diabetes on World Diabetes Day
BRIDGE-1 Comprehensive Care Program for Type 1 Diabetes for Training ~400 Physicians and Benefiting 1,000 Children
Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd., today announced that it has tied up with the Research Society for the Study of Diabetes in India (RSSDI), Asia’s largest organization of researchers and healthcare professionals for diabetes, to launch a Comprehensive Care Program, BRIDGE-1, the Biocon & RSSDI Initiative for Diabetes Knowledge in Type 1 patients.
India has among the largest population of children and adolescents living with Type 1 diabetes in the world with an estimated 1 million children and adolescents dealing with this condition as of 2019, with the number increasing every year. To address the issue of Type 1 diabetes in children in a holistic manner, Biocon Biologics will work together with RSSDI to identify and train ~400 physicians in different districts across the country. Biocon Biologics will enable these HCPs with a free supply of its insulins portfolio to help over 1,000 children with Type 1 diabetes, from the marginalized communities, who otherwise cannot afford this therapy.
As a part of this initiative, RSSDI teams will develop the training material, as well as, will train these physicians, to create awareness on effective diabetes management in Type 1 patients, among their peers, and community at large in their respective districts. Biocon Biologics will provide, educational and other diabetes awareness materials for these training programs as well as will facilitate organizing of these events.
As the world celebrates the 100th anniversary of the discovery of insulin, a therapy that has transformed Type 1 diabetes from a once-fatal diagnosis into a chronic, manageable condition, Biocon Biologics has expanded its universal access program to include children with Type 1 diabetes from marginalized communities in India.
Addressing the Biocon Biologics Scientific Symposium at the 49th Annual Conference of RSSDI held to commemorate World Diabetes Day on November 14, 2021, Kiran Mazumdar-Shaw, Executive Chairperson, Biocon and Biocon Biologics, said: “As a part of the centenary celebrations of the discovery of insulin, Biocon Biologics has expanded its universal access program to address the needs of young people with Type 1 diabetes in India in collaboration with RSSDI. With the help of ~400 physicians across the country, we aim to provide global quality, lifesaving insulins to over 1,000 children who otherwise cannot afford this therapy.
“Through our various access initiatives, Biocon Biologics is committed to enabling affordability, accessibility and availability of our insulins to the most underserved and vulnerable sections of the diabetes population in India,” she added.
Dr Banshi Saboo, President and Organising Chairman, RSSDI, said: “We are delighted to associate with Biocon Biologics to improve diabetes management for better patient outcomes, especially the marginalised who cannot afford the high cost of medicines. We are glad to be able to improve the quality of life for thousands of people with diabetes.”
At the symposium, Biocon Biologics presented the clinical study data submitted to the U.S. Food and Drug Administration based on which the Company received world’s first interchangeability approval for its biosimilar Insulin Glargine. This interchangeability approval for biosimilar Insulin Glargine by the U.S. FDA, another first to Biocon Biologics’ credit, is a testament to the Company’s scientific excellence and robust quality comparability data. It is a game changing achievement as the designation will allow substitution of the product at the pharmacy counter, thus expanding patient access in the U.S. Biocon Biologics’ biosimilar Insulin Glargine has been available to patients in India since 2009. The Company has served over 1 million people with diabetes in India through its insulins portfolio, which includes Insulin Glargine and recombinant human insulin in various presentations.
As a credible, global insulins player, Biocon Biologics is taking forward its mission of expanding affordable access to quality insulins for people with diabetes across the world. To commemorate 100 years of insulin discovery, Biocon Biologics is observing the Diabetes Awareness Month with a series of activities viz., HCP Engagement through its digital i-connect platform and face-to-face interactions, a Diabetes Awareness Campaign on Social Media, Diabetes Detection Camps, as well as Walkathons with participating HCPs for raising awareness on Diabetes.
About Type 1 Diabetes in Children & Adolescents in India India has the maximum number of children with Type 1 diabetes globally, as per IDF Diabetes Atlas 2019. As of 2019, over 1 million children and adolescents had Type 1 diabetes. India leads in both existing and new cases of Type 1 diabetes. There were 15,900 new cases of Type 1 diabetes in India, followed by 14,700 cases in US and 7,300 cases in Brazil. India leads with 95,600 existing cases of Type 1 diabetes among children up to the age of 14, followed by 94,200 in USA and 51,500 in Brazil.
Cipla ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Emerging Markets Index
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") announced today that it has been selected in the S&P Dow Jones Sustainability Index (DJSI) for the Emerging Markets for 2021. The DJSI family of indices is operated by one of the world's leading index providers S&P Dow Jones. The Emerging Markets Index for the year comprises of 108 companies from 12 emerging economies, including China, Brazil, South Africa and Taiwan.
Created jointly by S&P Dow Jones Indices and SAM, the DJSI is the gold standard for corporate sustainability, and is highly regarded by global investors and financial analysts looking at ESGbased investments. The DJSI follows a best-in-class approach, assessing sustainability leaders from each sector on a global and regional level. The selection process included the world’s largest ~4000 listed companies, which underwent a rigorous assessment on Economic & Governance, Social & Environmental parameters such as corporate governance, ethics, risk management, climate change mitigation, stakeholder engagement, access to medicine, quality, corporate social responsibility and human resource practices.
As of November 12, 2021, Cipla performed in the top decile in the pharmaceutical Industry in the S&P Global Corporate Sustainability Assessment, with a ranking of 93 percentile in the industry, meaning 93% of companies reached an equal or lower ESG Score.
The Company significantly improved performance in parameters like strategy to improve access to drugs or products, human capital development, tax strategy and climate strategy compared to last year
Commenting on the ranking, Mr. Umang Vohra (MD and Global CEO, Cipla Limited) said, “The selection into S&P Dow Jones Sustainability Index Emerging Markets is a testament to our commitment towards sustainability, which is at the core of our DNA. We are delighted to be recognized for our efforts in climate action and social impact, coupled with strong corporate governance. This recognition strengthens our belief in investing in greener technology and processes, creating social impact for communities and serving the markets to create for healthier people and a healthier planet. We remain committed to building ecosystems for accessible and patient centric quality healthcare, underpinned by industry leading practices.”
With the aim of reaching non-fossil fuel share of 40% by 2030, in January 2021, Cipla became the first pharmaceutical company in Maharashtra to invest in group captive open access solar power project of 30 MW capacity, spread across 115 acres. This has contributed to Cipla’s decarbonizing goals, with the company now sourcing ~25% of its energy from renewable sources in the current year. Additionally, Cipla is also a constituent of the MSCI All Country World Index (ACWI) and has an ESG Rating of BB; as well as a constituent of FTSE4Good Index Series for the three consecutive years.
Infosys Science Foundation to Announce the Winners of the 13th Infosys Prize
The Infosys Science Foundation (ISF) will announce and felicitate the laureates of the Infosys Prize 2021 on December 02, 2021. The Infosys Prize celebrates success in research and stands as a marker of excellence in science and research. It also aims to inspire young scholars to choose a vocation in research.
The Prize comprises a gold medal, a citation, and a purse of USD 100,000 (or its equivalent in Rupees) and is awarded in six categories: Engineering and Computer Science, Humanities, Life Sciences, Mathematical Sciences, Physical Sciences, and Social Sciences. Winners will be felicitated by Gagandeep Kang, FRS - Professor at CMC Vellore, Infosys Prize laureate and one of India’s leading virologists
A distinguished international jury, composed of leaders in each of these fields, evaluates the work and achievements of the nominees against stringent standards of international research, placing the winners on par with the finest researchers in the world.
“The pandemic has re-established the need for science to be in the limelight, to cut across the traditional boundaries and stretch across various disciplines. The interaction between science and society ensures that knowledge is exchanged, tested, and refined in order to respond to societal needs and global challenges. The Infosys Prize aims to recognize fundamental and applied research, both of which ultimately make a difference to our society,” said Kris Gopalakrishnan, President – Infosys Science Foundation.
Since its inception in 2009, Infosys Science Foundation has felicitated the work of 74 laureates, from institutes like the IITs, IISc, ISIs, TIFR and NCBS as well as CSIR labs across the country, and niche research institutes like JNCSAR and Harish Chandra Research Institute.
PTC India Financial Services (PFS) selects Resurgent Power Ventures Pte Ltd, Singapore as Lender’s Nominee for Northern Indian Transmission Power Line Project
PFS is pleased to inform that it has selected M/s Resurgent Power Ventures Pte Ltd, Singapore as its nominee to acquire 100% shareholding in NRSS XXXVI Transmission Limited’s power transmission project in Northern India. Resurgent is 26% owned by Tata Power with ICICI Bank, Power Platform Ltd and Kuwait Investment Authority holding the balance 74% shareholding. NRSS XXXVI is a wholly owned subsidiary of M/s Essel Infra Projects Ltd (EIPL) which won bid to strengthen the transmission system in the Northern Region in the states of Rajasthan, Haryana and Uttarakhand along with LILO of Sikar-Neemrana 400 kV D/C at Babai, Rajasthan.
Says, Dr. Pawan Singh, MD&CEO, PTC Financial Services, “Resurgent was selected as lenders nominee to acquire 100% shareholding subsequent to a transparent global bidding process initiated by PFS to choose a new bidder by exercising its right to appoint a nominee under the “Substitution Rights of the Lenders” as per Transmission Service Agreement (TSA). The process is concluded and Letter of Intent (LoI) has been issued by PFS to the highest bidder. Subsequent regulatory approval is under process.”
PTC India Financial Services Ltd (PFS) sanctioned a loan of Rs. 306 Crores to NRSS XXXVI Transmission Limited after it was awarded the project through competitive bidding initiated by Ministry of Power (MoP) through Bid Process Coordinator (BPC) REC Transmission Power Company Limited. As sole lender, PFS disbursed around Rs. 206.92 crores out of the sanctioned loan amount. The account started showing indication of stress in the second quarter of FY19-20 on account of liquidity issue in the promoter group and later on became an NPA.
In the process, PFS to receive resolution amount close to book value of the account. Apart from the above account, PFS during last three years i.e. FY18-19, FY19-20 and FY 20-21 has resolved 10 stressed accounts (principal outstanding cumulatively ~Rs. 1161 crores) through multi-pronged approach such as sale to ARC, resolution under IBC in NCLT, acquisition & sale of assets under SARFAESI and through One Time Settlement (OTS) offer from the promoter or new developer. PFS is also in advance stage of resolving another stressed account. With resolution of captioned account, there is huge improvement in PFS’s Net NPA value
TCS Helps Juniper Networks Digitally Transform Customer Experience
Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, announced that it has worked alongside Juniper Networks, a leader in secure, AI-driven networks, to successfully roll out a new service platform to deliver superior experiences to its customers and partners.
As part of its vision to deliver experience-first services, Juniper is transforming its digital support tools to simplify experiences for IT and operations teams running networks. As part of this strategy, Juniper Networks chose TCS, their trusted transformation advisor, to digitally reimagine customer service experiences and make them intelligent, personalized, and easy-to-use for its customers across various industries.
TCS leveraged its deep contextual knowledge of Juniper’s business and extensive experience in the networking industry and 'Web-First' customer service frameworks, to design and deliver a new Customer Experience Center platform that enables seamless, consistent, and real-time omnichannel experiences. Intelligent routing and simplified case management processes have resulted in improved first call resolutions and reduced case resolution times, enhancing customer satisfaction. This future-ready, agile digital platform will enable new capabilities helping Juniper Networks realize its growth and transformation vision.
“Experience-first stands at the core of Juniper’s values and growth. TCS has been a valuable advisor in delivering a key, next-generation digital support tool that will simplify experiences for IT and operations professionals,” said Derrell James, EVP, Global Services, Juniper Networks. “We look forward to continuing our relationship with TCS as we work together to build new initiatives for enhanced customer experiences.”
“TCS has been Juniper Networks’ strategic partner in several transformation programs over the years. We are delighted to have worked with Juniper to build their digital future-ready customer experience platform. TCS’ deep domain and CX capabilities, customer centricity, and expertise in powering large transformation programs, helped drive this highly complex initiative and deliver an exceptional product,” said V Rajanna, Global Head, Technology Business Unit, TCS.